NDC67457-0397-99: RANITIDINE INJECTION.
The RANITIDINE INJECTION is a the manufacturer industrial component. Key specifications include features_provided: STERILE, primary_container_type: VIAL, SINGLE DOSE, protective_storage_feature: SUBJECT TO DAMAGE BY FREEZING, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 10, primary_container_content_quantity: 2.000 MILLILITERS. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-208-5955, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| features_provided | STERILE |
| primary_container_type | VIAL, SINGLE DOSE |
| protective_storage_feature | SUBJECT TO DAMAGE BY FREEZING |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 10 |
| primary_container_content_quantity | 2.000 MILLILITERS |
| active_medicament_medicinal_strength | 25.000 MILLIGRAMS RANITIDINE EQUIVALENT PER MILLILITER |
| part_name_assigned_by_controlling_agency | RANITIDINE INJECTION USP 25MG/ML 2ML SINGLE DOSE VIAL 10S |
| NSN | 6505-01-208-5955 |
| PRIMARY CONTAINER CONTENT QUANTITY | 2.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| FEATURES PROVIDED | STERILE |
| PRIMARY CONTAINER TYPE | VIAL, SINGLE DOSE |
| PROTECTIVE STORAGE FEATURE | SUBJECT TO DAMAGE BY FREEZING |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | RANITIDINE INJECTION USP 25MG/ML 2ML SINGLE DOSE VIAL 10S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 25.000 MILLIGRAMS RANITIDINE EQUIVALENT PER MILLILITER |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |
No substitute or cross-reference records for this part.